Summary of Trading Off The Bottom - March 8. At .0002:

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
278
Summary of Trading Off The Bottom - March 8.

At .0002:

December 8: 3M
December 11: 6M
December 12: 3M
December 13: 10M
December 14: 52M
December 15: 14M
December 18: 19M
December 19: 14M
December 20: 22M
December 21: 18M
December 22: 7M
December 26: 34M
December 27: 24M
December 28: 24M
December 29: 43M
January 2: 17M
January 3: 13M
January 4: 9M
January 5: 3M
January 8: 12M
January 9: 10M
January 10: 20M
January 11: 28M
January 12: 10M
January 16: 30M
January 17: 4M
January 18: 8M
January 19: 13M
January 22: 8M
January 23: 5M
January 24: 3M
January 25: 21M
January 26: 5M
January 29: 2M
January 30: 3M
January 31: 6M
February 1: 4M
February 2: 11M
February 5: 2M
February 6: 2M
February 7: 5M
February 8: 2M
February 9: 4M
February 12: 2M
February 13: 2M
February 14: 4M
February 15: 2M
February 16: 1M [rounded down]
February 20: 5M
February 21: 4M
February 22: 6M [rounded up]
February 23: 5M
February 26: 10M
February 27: 10M
February 28: 8M
March 1: 5M
March 2: 2M
March 5: 9M
March 6: 8M
March 7: 2M
March 8: 3M

Total: 641M

At .0001:

December 7: 415M [260M bought on bid / 155M bought on ask].
December 8: 366M
December 11: 8M
December 12: 219M
December 13: 22M
December 14: 25M
December 15: 1M
December 19: 3M
December 20: 19M
December 21: 6M
December 22: 3M
December 23: 2M
December 28: 10M
December 29: 5M
January 2: 2M
January 3: 12M
January 4: 9M
January 5: 2M
January 8: 20M
January 10: 7M
January 11: 5M
January 12: 2M
January 16: 8M
January 18: 2M
January 19: 15M
January 23: 1M
January 24: 2M
January 25: 3M
January 29: 1M
January 30: 1M
January 31: 9M
February 1: 6M
February 5: 2M
February 7: 1M
February 8: 1M
February 12: 5M [rounded up]
February 13: 5M [rounded down]
February 14: 3M
February 15: 1M
February 20: 10M
February 22: 4M [rounded down]
February 23: 3M [rounded up]
February 26: 4M
February 27: 20M
February 28: 3M
March 1: 3M
March 5: 3M [rounded up]
March 6: 12M [rounded down]
March 7: 3M

Total 1.065 B

In addition the following quantities of .0001s may be in the hands of retail investors if not sold even on December 7:

November 29: 4M
December 5: 170M
December 6: 113M

Total: 287M

Discounting late print of 90M + 82,540,103 at .00098 Form T on December 12 which did not got to retail.

Discounting late print of 4 x 90M + 80.699.580M at .000098 Form T on December 7 which did not go to retail.

Discounting assumed mirror trades of 4 x 90M + 20,000,200 at .000098 then at .0001 on December 5. Might need to assume later that 380M or 760M acquired at .0001 - will become evident when .0002s and .0003s bought out.

Discounting assumed mirror trades of 2 x 90M + 56,499,900 at .0001 then .000098 on November 29. Might need to assume later that 236M or 472M acquired at .0001 - will become evident when .0002s and .0003s bought out.









Tersis Technologies, Inc. (TERS) Stock Research Links

TERS Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Markel's Reinsurance Shift with $4.8B Deal: Strategic Move?

Updated Category News Views 100

Weaving Through Complex Insurance Terrain When Markel Insurance pulls a move on the chessboard that involves $4.8 billion in subject reserves, we better pay attention. The insurance bigwig has inked a reinsurance deal with Enstar. This plan, they say, will help them focus more on their specialty insurance game while tidying up the loose ends in their global reinsurance...

Continue Reading
Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

Updated Category News Views 117

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Continue Reading
?atwogang Leads Tiltify's Impact Creator Class of 2026

Updated Category News Views 60

Charity Meets Creativity: A New Era Unveiled Who would have thought? Charitable fundraising is no longer just about writing checks. It's about creativity, community, and leveraging tech to drive change. Enter Tiltify's Creator Impact Class of 2026—proof that we're living in a brave new world where internet creators are the kings and queens of giving. ?atwogang Takes...

Continue Reading
Alchemy's Texas Move: Strategic Growth or Gamble?

Updated Category News Views 80

Making a Splash in Texas IT Services Alchemy Technology Group's acquisition of Freeit Data Solutions isn't just another drop in the tech pond; it's a cannonball aimed at shaking up the IT and cybersecurity scenes in Texas. By bringing Freeit's impressive 16-year track record under its wing, Alchemy is flexing its muscles in a region already bustling with IT infrastructure...

Continue Reading
Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip

Updated Category News Views 34

Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...

Continue Reading
Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 49

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 66

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Palmdale Propane Expands with Affordable Gas Buy

Updated Category News Views 50

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Continue Reading
Northeast Indiana Bancorp Shows Solid Third Quarter Gains

Updated Category News Views 47

Holding Steady in a Shaky Market In a market often rocked by turbulence, it seems Northeast Indiana Bancorp, Inc. has found a decent footing to stand on. Announcing their third-quarter results for 2026, they’ve posted net income of $1.991 million, showcasing a neat jump from the $1.793 million in the same period last year. Not bad at all for the parent company of First...

Continue Reading

Top 5 Most Recently Viewed Articles

Boosty Labs Elevates Leadership to Fuel 2025 Vision

Updated Category News Views 170

Boosty Labs Moves Forward with Strategic Leadership Changes Boosty Labs, a prominent name in Blockchain, Bitcoin, and Web3 development, is taking a substantial leap forward. As the company prepares for significant growth, the leadership team has undergone key changes aimed at driving operational excellence and innovation. New Roles for Vitalii Yatskiv and Denys Doronin In...

Continue Reading
Sinclair Inc. Elevates Leadership With Key Promotions

Updated Category News Views 236

Sinclair Inc. Elevates Leadership With Key Promotions BALTIMORE - Sinclair Inc. (NASDAQ: SBGI), a significant force in the media landscape recognized for its local news and sports coverage, with a market capitalization of $963 million, has recently elevated several key executives within its organizational structure and various subsidiaries. These strategic executive...

Continue Reading
Nasus Pharma's IPO: Paving the Way for Innovative Treatments

Updated Category News Views 172

Nasus Pharma Completes Initial Public Offering Nasus Pharma Ltd. (NYSE: NSRX) recently celebrated the successful conclusion of its initial public offering (IPO), marking a significant milestone for the company. This clinical-stage pharmaceutical firm, based in Israel, specializes in developing innovative intranasal products designed for treating emergency medical...

Continue Reading
Discover the Compact Keurig® K-Mini Mate™ Brewer Today

Updated Category News Views 105

Introducing the Keurig® K-Mini Mate™ Brewer The world of coffee brewing has evolved with the introduction of the Keurig® K-Mini Mate™ Brewer. This remarkable machine, available exclusively at Target, marks a significant leap in convenience and taste. Notably small at just 4 inches wide, this brewer is perfect for anyone who values space without wanting to sacrifice...

Continue Reading
Explore Telix Pharmaceuticals' Latest Innovations in Urology

Updated Category News Views 179

Join Telix Pharmaceuticals for a Pioneering Webinar Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) is excited to extend an invitation to investors for a comprehensive webinar centered on the company’s leading-edge developments in urology. This event will highlight innovative approaches to treating prostate and kidney cancers, showcasing the remarkable potential...

Continue Reading